Literature DB >> 23984995

Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence.

Abby B Siegel, Hashem B El-Serag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23984995      PMCID： PMC4083736          DOI： 10.1586/17474124.2013.814884

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN： 1747-4124            Impact factor:   3.869


× No keyword cloud information.
  35 in total

1.  Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression.

Authors:  Eek Joong Park; Jun Hee Lee; Guann-Yi Yu; Guobin He; Syed Raza Ali; Ryan G Holzer; Christoph H Osterreicher; Hiroyuki Takahashi; Michael Karin
Journal:  Cell       Date:  2010-01-22       Impact factor: 41.582

2.  Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C.

Authors:  Gowtham A Rao; Prashant K Pandya
Journal:  Gastroenterology       Date:  2010-09-15       Impact factor: 22.682

3.  Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer.

Authors:  Steven M Lipkin; Elizabeth C Chao; Victor Moreno; Laura S Rozek; Hedy Rennert; Mila Pinchev; Diana Dizon; Gad Rennert; Levy Kopelovich; Stephen B Gruber
Journal:  Cancer Prev Res (Phila)       Date:  2010-04-19

4.  Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.

Authors:  Vasilios G Athyros; Konstantinos Tziomalos; Thomas D Gossios; Theodora Griva; Panagiotis Anagnostis; Konstantinos Kargiotis; Efstathios D Pagourelias; Eleni Theocharidou; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Lancet       Date:  2010-11-23       Impact factor: 79.321

5.  Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids.

Authors:  Sharookh B Kapadia; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

6.  Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.

Authors:  Hashem B El-Serag; Thomas Tran; James E Everhart
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

7.  Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus.

Authors:  Ichiro Konishi; Yoichi Hiasa; Syuichiro Shigematsu; Masashi Hirooka; Shinya Furukawa; Masanori Abe; Bunzo Matsuura; Kojiro Michitaka; Norio Horiike; Morikazu Onji
Journal:  Liver Int       Date:  2009-04-28       Impact factor: 5.828

8.  Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis.

Authors:  Jianghong Wu; W Wei-Lynn Wong; Fereshteh Khosravi; Mark D Minden; Linda Z Penn
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

9.  Statin therapy and serum transaminases among a cohort of HCV-infected veterans.

Authors:  Louise M Henderson; Shital Patel; Thomas P Giordano; Linda Green; Hashem B El-Serag
Journal:  Dig Dis Sci       Date:  2010-01       Impact factor: 3.199

10.  Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006.

Authors:  Arupendra Mozumdar; Gary Liguori
Journal:  Diabetes Care       Date:  2010-10-01       Impact factor: 19.112
View more
  3 in total

1.  Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.

Authors:  Ali Zarrinpar; Claire M Faltermeier; Vatche G Agopian; Bita V Naini; Michael P Harlander-Locke; Fady M Kaldas; Douglas G Farmer; Ronald W Busuttil
Journal:  Liver Int       Date:  2018-12-02       Impact factor: 5.828

Review 2.  Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.

Authors:  Amit G Singal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-15       Impact factor: 11.382

3.  Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery.

Authors:  Elias Khajeh; Arash Dooghaie Moghadam; Pegah Eslami; Sadeq Ali-Hasan-Al-Saegh; Ali Ramouz; Saeed Shafiei; Omid Ghamarnejad; Sepehr Abbasi Dezfouli; Christian Rupp; Christoph Springfeld; Carlos Carvalho; Pascal Probst; Seyed Mostafa Mousavizadeh; Arianeb Mehrabi
Journal:  BMC Cancer       Date:  2022-01-21       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.